BCL2 and cancer: We accessed the DepMap Cancer Dependency Map portal at https://depmap.org/as provided by the Broad Institute (on 5 March 2023) to generate a list of cancer cell lines that are the most sensitive to BCL2 loss in a genome-wide CRISPR loss-of-function screen.